Susie H - University of Southern California

The only genes that had an OR higher than two were the SLC6A4 for all addictions, the. ADH1B for alcohol dependence, and BDNF for methamphetamine dependence.







Investigation of the HSPG2 Gene in Tardive Dyskinesia - CORE
Sanitaria de Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain; almudena.gil@usc.es (A.G.-R.); sheila.recarey.rama@usc.es (S.R. ...
Realizing the Promise of Pharmacogenomics - Georgetown University
Sustained responders exhibited 112 distinct genes and regulatory patterns linked to ketamine efficacy, with key biomarkers including DENN domain containing 5B ( ...
Molecular genetics of substance use disorders - DRUGZ
Tardive dyskinesia (TD) is a movement disorder that may develop in schizophrenia patients being treated long-term with antipsychotic medication.



Autres Cours:

Ontogeny and Pharmacogenetics: Determinants of Age-Associated ...